Press Releases
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Phase III study met all co-primary and secondary endpoints and achieved statistically significant resultsWorld pharma today/-press releases/-Allergan Plc and Gedeon Richter Plc. announced positive results...
Press Releases
Successful ExCeL debut for Infrarail and CITE 2016
With unprecedented levels of rail investment and the rise of national infrastructure up the political agenda, there was an upbeat mood at the Infrarail 2016...
Press Releases
Reed Sinopharm Hosts World’s Largest Healthcare Event – tHIS in Shanghai
SHANGHAI, April 21, 2016 /PRNewswire/ -- The Health Industry Summit (tHIS) 2016 opened in Shanghai at the National Exhibition and Convention Center on April 17. ...
Press Releases
AstraZeneca completes divestment of Imdur to China Medical System Holdings
AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and its...
Press Releases
European Medicines Agency Issues Positive Opinion for the Use of IMBRUVICA® (ibrutinib)
AbbVie, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive...
Press Releases
Biogen Appoints Michael Ehlers Executive Vice President, Research and Development
Biogen announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development. World pharma today/Press releases /-Dr. Ehlers...
Press Releases
Sunovion Pharmaceuticals Inc reports Two Phase 3 Clinical Studies for People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Evaluating SUN-101/eFlow (glycopyrrolate)
The GOLDEN-3 and GOLDEN-4 Phase 3 trials evaluating SUN-101/eFlow® in people with moderate-to-very severe COPD met their primary endpoint with a statistically significant change from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.